All News

As OTC hearing devices emerge and technologies advance, pharmacists can provide trustworthy recommendations and advice to patients

Trial data bolster the role of nivolumab and nivolumab-based combinations in both early and metastatic stages of multiple cancer types, especially in patient groups with high unmet needs.

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of the EGFR signaling pathway.

Karline Peal, MBA of Vanderbilt Ingram Cancer Center discusses the positive impact technology has had in health care and how it can be implemented in the future.

Larger institutions have continued to treat patients who needed carboplatin or cisplatin; however, the survey results don’t include smaller cancer centers that may face access challenges.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses being the second pharmacist in IDSA history to receive a society award and what this means not only for her, but for the field.

SYNCHRONIZE-1, SYCHRONIZE-2, SYNCHRONIZE-CVOT will evaluate survodutide for overweight and obesity.

Investigators suggest that the Bacille Calmette–Guérin vaccine, which prevented tuberculosis in nonhuman primates infected with SIV, can also protect against HIV.

The president of HOPA discusses the importance of mentorship in oncology pharmacy as well as the value of HOPA’s mentorship initiatives.

Although education and training have historically been considered the primary factors influencing pay, the survey results challenge this notion.

Pharmacists should educate patients on proper application of OTC hair loss products and help identify any medications that may be contributing.

Although the brand name manufacturer updated the label after the FDA’s request, generic manufacturers have not all followed suit.

Encorafenib (Braftovi; Pfizer Inc) and binimetinib (Mektovi; Pfizer Inc) approved for the treatment of patients with metastatic non-small cell lung cancer who harbor a BRAF V600E mutation.

Collaboration between AI-based platforms and health care organizations offers promising results.

New products and medications can be used as single agents or in combination with other agents for optimal treatment outcomes.

Jennifer Mathieu, MA from the Academy of Managed Care Pharmacy (AMCP) discusses what to expect from AMCP Nexus 2023 and some of the sessions she is looking forward to.

Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.

Black men had 27% lower odds of an ideal cardiovascular health score compared to White men, whereas Black women had 55% lower odds compared to White women.

The study authors note that it is important for expectant mothers to use antibiotics appropriately and when necessary, as well as monitor their child after birth.

The clinical trial success in canines may have broader implications for applicability.

If health care professionals want to increase access and care in these underrepresented communities, an important first step is also increasing the representation of those groups in health care itself.

Health promotional strategies should account for social contexts and cultural perspectives to increase the number of individuals who choose to test for HIV.

Pre-exposure prophylaxis found to provide peace of mind for patients at risk of HIV, and coupled with frequent HIV testing in the health care setting, lowers the perceived risk of contracting the disease.

Pharmacy Times will be providing exclusive session coverage and interviews with presenters for the Academy of Managed Care Pharmacy Nexus 2023 conference.

A single-center experience at a tertiary medical center precision medicine clinic provides insight.

Study shows that interventions may help to personalize care that meets the individual needs of patients with HIV and to improve mental health outcomes.

Primary care physicians, particularly in family medicine, offer PrEP at a significantly low rate, despite US Preventive Services Task Force recommendations.